A gel-based proteomic comparison of human cerebrospinal fluid between inflicted and non-inflicted pediatric traumatic

Wei-Min Gao1, Mandeep S Chadha, Rachel P Berger

  • 1Department of Critical Care Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15260, USA.

Journal of Neurotrauma
|February 1, 2007
PubMed

Insights

Inflicted traumatic brain injury (iTBI) in infants shows distinct cerebrospinal fluid (CSF) protein profiles compared to non-inflicted TBI. Proteomics identified key protein differences, aiding understanding of iTBI pathophysiology.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Proteomics

Background:

  • Traumatic brain injury (TBI) is a leading cause of infant mortality, with inflicted TBI (iTBI) being the primary cause.
  • Cerebrospinal fluid (CSF) protein composition changes with central nervous system pathologies, offering a window into brain injury.
  • Understanding the differences between iTBI and non-inflicted TBI (nTBI) is crucial for diagnosis and treatment.

Purpose of the Study:

  • To compare the CSF proteomic profiles of pediatric iTBI and nTBI patients.
  • To identify specific proteins that differ between iTBI and nTBI.
  • To explore potential biomarkers for differentiating inflicted from accidental TBI in infants.

Main Methods:

  • Proteomic analysis using two-dimensional (2-D) difference in gel electrophoresis (DIGE) and mass spectrometry (MS).
  • Comparison of pooled CSF samples from 13 pediatric iTBI and 13 nTBI patients with severe injuries.
  • Analysis of approximately 250 protein spots with high inter-gel reproducibility (90%).
  • Validation of key protein changes using Western blot.

Main Results:

  • Haptoglobin (HP) isoforms were approximately fourfold higher in nTBI compared to iTBI.
  • Prostaglandin D(2) synthase (PGDS) levels were 12-fold higher in iTBI versus nTBI.
  • Cystatin C (CC) levels were sevenfold higher in iTBI versus nTBI.
  • Confirmed significant differences in HP, PGDS, and CC between iTBI and nTBI groups.

Conclusions:

  • Proteomic analysis of CSF reveals distinct protein signatures between iTBI and nTBI.
  • Specific proteins like HP, PGDS, and CC may serve as biomarkers to differentiate injury types.
  • These findings contribute to understanding the unique pathophysiology of iTBI and may aid in clinical diagnosis.